Randomized, Placebo-Controlled, Double-Blind, Phase 2 Study of Gemcitabine-Cisplatin Combined With Two Different Doses of LY293111 or Placebo in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2014
At a glance
- Drugs Etalocib (Primary) ; Cisplatin; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 21 Nov 2009 Additional lead trial investigator identified as reported by M.D. Anderson Cancer Center record.
- 21 Nov 2009 New source identified and integrated (M.D. Anderson Cancer Center).
- 15 Oct 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History